MEMORIAL SLOAN KETTERING CANCER CENTER (New York, NY), November 12, 2019 – Memorial Sloan Kettering (MSK) has named three investigators as the recipients of this year’s Paul Marks Prize for Cancer Research. The award recognizes promising scientists for their accomplishments in the area of cancer research. The winners for 2019 are Nathanael Gray, PhD, of the Dana-Farber … Continued
WEILL CORNELL MEDICINE – A protein that breast, lung and other cancers use to promote their spread—or metastasis—to the brain, has been identified by a team led by Weill Cornell Medicine and New York-Presbyterian investigators. The protein, CEMIP, will now be a focus of efforts to predict, prevent and treat brain metastases, which are a … Continued
September 30, 2019, New York, NY (BUSINESS WIRE): The Pershing Square Sohn Cancer Research Alliance (PSSCRA) today announced the opening of applications for its 2020 Prize for Young Investigators in Cancer Research. The prize of $200,000 per year for up to three years is awarded annually to at least six New York City area-based scientists. … Continued
COLUMBIA UNIVERSITY IRVING MEDICAL CENTER/EUREKALERT – Columbia University will award the 2019 Louisa Gross Horwitz Prize to three scientists: Lewis C. Cantley, Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center, New York, NY, USA, David M. Sabatini, Massachusetts Institute of Technology, Cambridge, Massachusetts, and Howard Hughes Medical Institute, Chevy Chase, MD, USA, and Peter K. … Continued
MIRAGE NEWS – A molecular pathway known for responding to cellular stress also produces pain-inducing molecules in immune cells in mice, according to a new study by scientists at Dana-Farber Cancer Institute, Weill Cornell Medicine and Wake Forest University School of Medicine. The investigators found that blocking this pathway can reduce pain. The findings, published online in the … Continued
PERSHING SQUARE SOHN PRIZE AWARDS $4.2M TO SEVEN “NEXT GENERATION” INNOVATORS IN CANCER RESEARCH The Pershing Square Sohn Cancer Research Alliance Has Invested Over $22 Million in the New York Life Science Ecosystem by Funding NYC’s Most Innovative Cancer Researchers NEW YORK, May 21, 2019 – The Pershing Square Sohn Cancer Research Alliance today announced … Continued
Cold Spring Harbor, NY — Dr. Bruce Stillman, President and CEO of Cold Spring Harbor Laboratory (CSHL), has been awarded the 2019 Canada Gairdner International Award in honor of his pivotal contributions to basic research. The Canada Gairdner International Award recognizes researchers who have made seminal discoveries or contributions to biomedical science. Dr. Stillman is being honored for “pioneering … Continued
Researchers at the Stanford University School of Medicine and their collaborators at other institutions have identified a link between how proteins bind to our DNA and how cancer develops. This finding may allow researchers to predict cancer pathways and long-term patient outcomes. The research focuses on chromatin, the DNA-protein complex where all genes reside. Specifically, it evaluates chromatin’s … Continued
October 1, 2018, New York, NY (BUSINESS WIRE): The Pershing Square Sohn Cancer Research Alliance (PSSCRA) today announced the opening of applications for its 2019 Prize for Young Investigators in Cancer Research. The prize of $200,000 per year for up to three years is awarded annually to at least six New York City area-based scientists. … Continued
NEW YORK (GenomeWeb) – New evidence has emerged today showing that the inactivation or alteration of cancer suppressor genes can take place even if DNA itself remains unaltered. Reporting in Nature, investigators demonstrated that changes in mRNA due to a process called intronic polyadenylation (IPA) can drive development of some cancers by altering gene expression in … Continued